Summary and general discussion 7 191 mocatest.org (no date). Available at: https://www.mocatest.org/ (Accessed: 31 December 2019). Mukku, S. S. R. et al. (2021) ‘Geriatric Depression and Cognitive Impairment—AnUpdate’, Indian Journal of Psychological Medicine. SAGE Publications Ltd, pp. 286–293. doi: 10.1177/0253717620981556. Nasreddine, Z. S. et al. (2005) ‘The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment’, Journal of the American Geriatrics Society, 53(4), pp. 695–699. doi: 10.1111/j.1532-5415.2005.53221.x. Nederlandse Vereniging voor Klinische Geriatrie (2014) Richtlijn ‘Diagnostiek en medicamenteuze behandeling van dementie’. Utrecht: CBO. Available at: https://www.nvvp.net/stream/richtlijndiagnostiek-en-behandeling-van-dementie-2014. Noel-Storr, A. H. et al. (2014) ‘Reporting standards for studies of diagnostic test accuracy in dementia: The STARDdem Initiative’, Neurology, 83(4), pp. 364–373. doi: 10.1212/WNL.0000000000000621. O’Caoimh, R., Timmons, S. and Molloy, D. W. (2016) ‘Screening for mild cognitive impairment: Comparison of “MCI Specific” screening instruments’, Journal of Alzheimer’s Disease. IOS Press, 51(2), pp. 619–629. doi: 10.3233/JAD-150881. Oren, N. et al. (2014) ‘The montreal cognitive assessment in cognitively-intact elderly: A case for ageadjusted cutoffs’, Journal of Alzheimer’s Disease, 43(1), pp. 19–22. doi: 10.3233/JAD-140774. Pendlebury, S. T. et al. (2015) ‘Routine cognitive screening in older patients admitted to acute medicine: Abbreviated mental test score (AMTS) and subjective memory complaint versus Montreal Cognitive Assessment and IQCODE’, Age and Ageing. Oxford University Press, 44(6), pp. 1000–1005. doi: 10.1093/ageing/afv134. Prince, M., Bryce, R. and Ferri, C. (2011) World Alzheimer Report 2011: The Benefits of Early Diagnosis and Intervention, World Alzheimer Report 2015. Available at: http://www.alz.co.uk/research/ WorldAlzheimerReport2011.pdf. Prince, M. and Comas-Herrera, A. (2016) ‘World Alzheimer Report 2016’. Available at: www.alz.co.uk. Ramírez, L. R. B. et al. (2014) ‘Validez de la escala de evaluación cognitiva de montreal (MoCA) para determinar deterioro cognitivo en pacientes con esquizofrenia’, Salud Mental. Instituto Nacional de Psiquiatria Ramon de la Fuente, 37(6), pp. 517–522. doi: 10.17711/sm.0185-3325.2014.062. Van Rheenen, T. E. et al. (2017) ‘Characterizing cognitive heterogeneity on the schizophrenia-bipolar disorder spectrum’, Psychological Medicine. Cambridge University Press, 47(10), pp. 1848–1864. doi: 10.1017/S0033291717000307. Van Rheenen, T. E. et al. (2020) ‘Current understandings of the trajectory and emerging correlates of cognitive impairment in bipolar disorder: An overview of evidence’, Bipolar Disorders. Blackwell Publishing Inc., pp. 13–27. doi: 10.1111/bdi.12821. Riddle, M. et al. (2017) ‘Longitudinal cognitive outcomes of clinical phenotypes of late-life depression HHS Public Access’, Am J Geriatr Psychiatry, 25(10), pp. 1123–1134. doi: 10.1016/j.jagp.2017.03.016. Rossetti, H. C. et al. (2011) ‘Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample’, Neurology, 77(13), pp. 1272–1275. doi: 10.1212/WNL.0b013e318230208a. Rund, B. R. et al. (2016) ‘Neurocognition and Duration of Psychosis: A 10-year Follow-up of FirstEpisode Patients’, Schizophrenia Bulletin. Oxford University Press, 42(1), pp. 87–95. doi: 10.1093/ schbul/sbv083.
RkJQdWJsaXNoZXIy MTk4NDMw